Clinical Trials Browser

Active not recruiting × naxitamab × Sarcoma × Clear all

NCT02502786 2025-10-07

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma

Phase 2 Active not recruiting

Osteosarcoma